Sign inGet started

Bellon Steven F.

Insider CIK 1831749 · FHTX Chief Scientific Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
FHTX Foghorn Therapeutics Inc. A Award deriv2026-01-302026-02-02300,000$5.71 $1.71M300,000SEC↗
FHTX Foghorn Therapeutics Inc. A Award deriv2025-01-222025-01-24140,000$4.37 $611.8K140,000SEC↗
FHTX Foghorn Therapeutics Inc. S Sale2024-09-092024-09-1120,000$9.50 $190.0K101,957SEC↗
FHTX Foghorn Therapeutics Inc. A Award deriv2024-01-242024-01-25110,000$3.06 $336.6K110,000SEC↗
FHTX Foghorn Therapeutics Inc. A Award deriv2023-01-262023-01-30100,000— $0100,000SEC↗
FHTX Foghorn Therapeutics Inc. M Exercise deriv2022-08-112022-08-151,858— $03,716SEC↗
FHTX Foghorn Therapeutics Inc. M Exercise2022-08-112022-08-151,858$3.72 $6.9K121,957SEC↗
FHTX Foghorn Therapeutics Inc. M Exercise deriv2022-05-252022-05-273,717— $05,574SEC↗
FHTX Foghorn Therapeutics Inc. M Exercise deriv2022-05-252022-05-27675— $00SEC↗
FHTX Foghorn Therapeutics Inc. M Exercise2022-05-252022-05-273,717$3.72 $13.8K120,099SEC↗
FHTX Foghorn Therapeutics Inc. M Exercise2022-05-252022-05-27675$0.73 $493116,382SEC↗
FHTX Foghorn Therapeutics Inc. A Award deriv2022-01-262022-01-28150,000— $0150,000SEC↗